Tag: people-familiar
-
Exclusive: Lonza in talks to buy Capsugel for more than $5 billion – sources
Swiss pharmaceutical manufacturer Lonza Group AG is in advanced talks to acquire Capsugel, a U.S. maker of capsule products and other drug delivery systems, for more than $5 billion, according to people familiar with the matter. The deal would come as Lonza seeks to boost its life sciences capabilities and produce a wider range of…
-
Texas to launch massive youth-athlete concussion study
AUSTIN, Texas (AP) — This week, Texas will launch what state officials say is the nation's largest effort to track brain injuries among young athletes.
-
TreeHouse Foods recalls some products citing salmonella risk
Packaged foods maker TreeHouse Foods Inc on Sunday recalled certain macaroni and cheese cup products containing cheddar cheese seasoning, saying they may be contaminated with salmonella. The company said no illnesses had been reported and that the products had been distributed nationwide through retail stores. Products being recalled are Big Win Original Macaroni & Cheese…
-
Exclusive: Pfizer weighs sale or spin-off of consumer health unit – sources
By Lauren Hirsch, Olivia Oran and Carl O'Donnell (Reuters) – U.S. drugmaker Pfizer Inc is evaluating a potential sale or spin-off of its consumer health division that could value the unit at as much as $14 billion, people familiar with the matter said on Wednesday. A Pfizer exit from the consumer health business, which includes…
-
Mylan working to finalize EpiPen Medicaid settlement: CFO
Generic drugmaker Mylan NV said on Wednesday it was working to finalize a settlement with the U.S. government over Medicaid rebates for its EpiPen emergency allergy treatment, adding that money set aside for the settlement led to a third quarter loss. The company had previously said it agreed to terms of a settlement set at…
-
Exclusive: Medivation succumbs to pressure to explore sale – sources
U.S. cancer drug maker Medivation Inc has decided to explore a sale following a $9.3 billion acquisition offer from France's Sanofi SA and interest from other companies, people familiar with the matter said on Monday. Pfizer Inc and Amgen Inc are among the companies that have signed non-disclosure agreements with Medivation, which allow them to…
-
Allergan profit beats estimates, share buybacks planned
The Dublin drugmaker on Tuesday said the planned $40 billion sale of its generics business to Teva Pharmaceutical Industries will close next month and that it will use $8 billion of the money to pay down company debt. Since the U.S. government torpedoed the merger, a deal that would have relocated Pfizer's legal domicile to…